CHOICE membership

K Care Healthcare Solutions t/as R & R Healthcare Equipment Pty Ltd - Fusion Comfort Chair Recall

A recall notice for Fusion Comfort Chair supplied by K Care Healthcare Solutions t/as R & R Healthcare Equipment Pty Ltd as the chair is labelled with a maximum user weight of 200kg. Testing has shown that at a weight of around 110kg, there was a potential for weld failure in the base assembly and if occupied, the chair could collapse.

The chair’s maximum user weight is 110kg.

K Care Healthcare Solutions t/as R & R Healthcare Equipment Pty Ltd - Fusion Comfort Chair

PRA No.

2020/18403

Date published

28 Jun 2020

Product description

Fusion Comfort Chair

Model 18040H

All Serial Numbers

ARTG 201862
(R & R Healthcare Equipment Pty Ltd - Chair)

What are the defects?

The chair is labelled with a maximum user weight of 200kg. Testing has shown that at a weight of around 110kg, there was a potential for weld failure in the base assembly and if occupied, the chair could collapse.

The chair’s maximum user weight is 110kg.

What are the hazards?

If the chair collapses while the chair is occupied, there is a risk of injury to the occupant or bystanders.

What should consumers do?

R & R Healthcare Equipment will provide affected consumers with a corrected label to replace the existing weight limit label.

If the occupant of the chair exceeds or is likely to exceed 110kg, consumers should immediately stop using the chair and contact R & R Healthcare Equipment or K Care Healthcare Solutions who will either:

  1. Replace the Fusion Comfort chair with the HiLite KA582KD chair, which is made of steel and tested to a maximum weight limited of 150kg; or
  2. Provide a credit on return of the affected chair(s).

For more information, consumers can contact K Care Healthcare Solutions on 1300 783 783.

Supplier

K Care Healthcare Solutions t/as R & R Healthcare Equipment Pty Ltd

Traders who sold this product

Healthcare equipment retailers and rehabilitation services

Where the product was sold

Australian Capital Territory

New South Wales

Queensland

South Australia

Victoria

Western Australia

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category

Pharma